Minimize Uncertainty – Make Informed Decisions – Succeed

Vaccines

Vaccines Today—January 9, 2026

January 9, 2026Fentanyl vaccine,Heplisav-B,bayer,Recombinant vesicular stomatitis virus Lassa vaccine,pfizer,Respiratory syncytial virus prefusion F vaccine,sanofi,mRNA-1010,Moderna,Hevaxin,BioNTech,BioPharma and Tech News,Vaccine news,Shingrix,Johnson and Johnson,RMR Sciences,Dynavax Technologies,IAVIScripps Research Institute,Multistage malaria vaccine

This vaccines update highlights key vaccine developments spanning early…

by LucidQuest

Respiratory

Respiratory Video Recap—January 9, 2026

January 9, 2026Bambusa Therapeutics,Apogee Therapeutics,cystic fibrosis,Progressive pulmonary fibrosis,sanofi,Pediatric asthma,BioPharma and Tech News,Parkinson’s disease psychosis,Boehringer Ingelheim,Type two inflammation,neurodegenerative diseases,GlaxoSmithKline,Krystal Biotech,Savara Pharmaceuticals,Respiratory News,INOVIO Pharmaceuticals,chronic obstructive pulmonary disease,Medicaid,Recurrent respiratory papillomatosis,Pulmonary diseases,Regeneron Pharmaceuticals,Progressive fibrotic lung diseases,severe asthma,Genetic respiratory diseases,chronic rhinosinusitis with nasal polyps,Human papillomavirus–related diseasesinterstitial lung disease,Transpire Bio

This respiratory update focuses on respiratory disease advances, including…

by LucidQuest

Respiratory

Respiratory Today—January 9, 2026

January 9, 2026Boehringer Ingelheim,Bambusa Therapeutics,INOVIO,Apogee Therapeutics,cystic fibrosis,Krystal Biotech,Exdensur,clinical trials,respiratory medicine,biologics,Savara,gsk,Invivyd,sanofi,Respiratory News,immunology,Dupixent,COPD,Monoclonal antibodies,Asthma,interstitial lung disease,BioPharma and Tech News,inhaled therapies,rare disease,regulatory affairs,Autoimmune Disease,Aqualung Therapeutics,nucala,Mabwell,pulmonary fibrosis,SoftOxCOVID-19,Transpire Bio

This respiratory update spotlights reflects strong momentum across respiratory…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A

January 9, 2026venture capital,clinical trials,obesity,GLP-1,biopharma,GIPR,amylin,Lucid Diligence Brief,payer access,metabolic diseasediligence

Lucid Diligence Brief: Alveus Therapeutics $159.8 million Series A Professional…

by Timos Papagatsias

Cardiovascular

Cardiovascular Today—January 8, 2026

January 8, 2026Conformal Medical,Ultromics,BioPharma and Tech News,Ventric Health,HEART FAILURE,Vivio Health,stroke,GIMM platform,Edwards Lifesciences,Bristol Myers Squibb,Cardiovascular News,Abbott,mitral regurgitation,Cytokinetics,Stereotaxis,Ceribell,SpectrumedicsAcesion Pharma,Gore Medical

This cardiovascular update spotlights key developments, regulatory milestones,…

by LucidQuest

Rare Disease news

Rare Disease Today—January 8, 2026

January 8, 2026Rare Disease News,Pompe diseaseamyotrophic lateral sclerosis,Alpha one antitrypsin deficiency,hemophilia,biomarin pharmaceutical,Spinal and bulbar muscular atrophy,pfizer,Otsuka Pharmaceutical,Niemann–Pick disease type C,roche,Immune thrombocytopenia,Immunoglobulin A nephropathy,sanofi,Prime Medicine,Duchenne Muscular Dystrophy,Italfarmaco,Fabry Disease,Chiesi Group,BioPharma and Tech News,Amicus Therapeutics,Cushings Syndrome,Corcept Therapeutics,Beam Therapeutics,Mitsubishi Tanabe Pharma,Shionogi,Nido Biosciences,myelofibrosis,Zevra Therapeutics,Fibrodysplasia Ossificans Progressiva,Uniphar Group,Ipsen,PANTHERx Rare Pharmacy,Paroxysmal Nocturnal Hemoglobinuria,Cellenkos

This rare disease update covers major regulatory approvals, strategic…

by LucidQuest

Immunology

Immunology Today—January 8, 2026

January 8, 2026Immune thrombocytopenia,Oncodermatology conditions,Immutep,astrazeneca,Savara Pharmaceuticals,sanofi,Paediatric plaque psoriasis,takeda,Cutaneous lupus erythematosus,Atopic Dermatitis,Regenexx,BioPharma and Tech News,Bonsai Health,Ulcerative Colitis,American Academy of Dermatology,Behcet’s disease,French Dermatology Society,Palisade Bio,Hoth Therapeutics,Soligenix,Elanco,Immunology News,Galapagos,InnoCare Pharma,Windward Bio,Systemic lupus erythematosus,Dermatomyositis,chronic spontaneous urticaria,Autoimmune pulmonary alveolar proteinosisJohnson and Johnson,Systemic psoriasis

This Immunology update captures a broad range of developments, including…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap—January 8, 2026

January 8, 2026Age-related macular degeneration,FDA,Spinal Muscular Atrophy,Fabry Disease,BioPharma and Tech News,Parkinson's Disease,Rett syndrome,Cell and Gene Therapy News,Taysha Gene Therapies,CAR T cell therapy,CRISPR gene editing,Leber hereditary optic neuropathy,Glycogen storage disease type one AFrench National Agency for the Safety of Medicines and Health Products,Transplant-associated thrombotic microangiopathy

This Cell and Gene Therapy video recap highlights major regulatory milestones,…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today—January 8, 2026

January 8, 2026Severe aplastic anemia,SCTbio,CRISPR Therapeutics,Fortrea,Spinal Muscular Atrophy,Vertex Pharmaceuticals,Huntington's disease,Leber hereditary optic neuropathy,Fabry Disease,ENCell,BioPharma and Tech News,Modalis Therapeutics,Colorectal Cancer,Minaris Regenerative Medicine,Marginal Zone Lymphoma,Cell and Gene Therapy Catapult,Dravet Syndrome,CAR-T superiority trials,uniQure,T-cell leukemia,CSL Behring,LAMA2-related congenital muscular dystrophy,Cell and Gene Therapy News,Glycogen storage disease type one A,Wiskott Aldrich syndromeMalignant glioma,Recessive dystrophic epidermolysis bullosa

This Cell & Gene Therapy update highlights momentum across cell and gene…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—January 8, 2026

January 8, 2026Chong Kun Dang Pharmaceutical Corporation,GENIXCURE,Alzheimer's Disease,S-RACE platform,Insilico Medicine,ImmunoStruct platform,BioPharma and Tech News,Excessive daytime sleepiness,obesity,Cognitive impairment,DEMENTIA,Sleep Apnea,metabolic disease,AI in Healthcare and Digital Health,Periodontal disease,Autism spectrum disorder,Dentomi,Phoenix Digital ClinicMindRank,Linus Health

This roundup covers major developments across artificial intelligence,…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Lilly to acquire Ventyx Biosciences

January 8, 2026clinical trials,Regulatory,immunology,IBD,biopharma,Lucid Diligence Brief,payer access,diligence,M&A,cardiometabolicoral therapies

Lucid Diligence Brief: Lilly to acquire Ventyx Biosciences Professional…

by Timos Papagatsias

Women's_Health

Women’s Health Video Recap—January 7, 2026

January 7, 2026Alzheimer's Disease,BioPharma and Tech News,HEART FAILURE,Women's Health News,Systemic lupus erythematosus,Major depressive disorder,Relapsing-remitting multiple sclerosis,Non-relapsing secondary progressive multiple sclerosisAlzheimer’s-related agitation,HER2-positive metastatic breast cancer

This Women’s Health video roundup brings together key regulatory decisions,…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.